Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945282678> ?p ?o ?g. }
- W2945282678 abstract "Type 2 diabetes mellitus (T2DM) is prevalent, with a dramatic increase in recent years. Moreover, its microvascular and macrovascular complications cause significant societal issues. The demand for new and effective antidiabetic therapies grows with each passing day and motivates organizations and individuals to pay more attention to such products. In this article, we focused on oral antihyperglycemic drugs patented in China and introduced them according to their antihyperglycemic mechanisms. By searching the website of State Intellectual Property Office of the People's Republic of China (http://www.sipo.gov.cn), 2500 antihyperglycemic patents for T2DM were identified and analyzed. These consisted of 4 patents for derivatives of herbal extracts (0.2%), 162 patents for herbal extracts (6.5%), 61 compositions for traditional Chinese medicine (TCM) (2.4%), 2263 patents for synthetic compounds (90.5%) and 10 (0.4%) patents of the combination of synthetic compounds and TCM. As the most common drugs for diabetes mellitus, synthetic compounds can also be classified into several categories according to their working mechanisms, such as insulin secretion promotor agents, insulin sensitizer agents, α-glucosidase inhibitors and so forth. This article discussed the chemical structure, potential antihyperglycemic mechanism of these antihyperglycemic drugs in patents in China." @default.
- W2945282678 created "2019-05-29" @default.
- W2945282678 creator A5010319430 @default.
- W2945282678 creator A5031299267 @default.
- W2945282678 creator A5037090796 @default.
- W2945282678 creator A5038965879 @default.
- W2945282678 creator A5044841786 @default.
- W2945282678 creator A5050497348 @default.
- W2945282678 creator A5052942089 @default.
- W2945282678 creator A5074161249 @default.
- W2945282678 creator A5081254368 @default.
- W2945282678 date "2019-05-21" @default.
- W2945282678 modified "2023-10-13" @default.
- W2945282678 title "Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus" @default.
- W2945282678 cites W1479698458 @default.
- W2945282678 cites W1518589347 @default.
- W2945282678 cites W1556514402 @default.
- W2945282678 cites W1700986470 @default.
- W2945282678 cites W175884836 @default.
- W2945282678 cites W1859248260 @default.
- W2945282678 cites W1968237817 @default.
- W2945282678 cites W1968368398 @default.
- W2945282678 cites W1971698096 @default.
- W2945282678 cites W1972131883 @default.
- W2945282678 cites W1973161349 @default.
- W2945282678 cites W1984252536 @default.
- W2945282678 cites W1991778481 @default.
- W2945282678 cites W2008075020 @default.
- W2945282678 cites W2011047431 @default.
- W2945282678 cites W2011172716 @default.
- W2945282678 cites W2012437459 @default.
- W2945282678 cites W2015569637 @default.
- W2945282678 cites W2016732441 @default.
- W2945282678 cites W2026413615 @default.
- W2945282678 cites W2028006649 @default.
- W2945282678 cites W2031032207 @default.
- W2945282678 cites W2032322539 @default.
- W2945282678 cites W2045063167 @default.
- W2945282678 cites W2051313176 @default.
- W2945282678 cites W2054951377 @default.
- W2945282678 cites W2060537536 @default.
- W2945282678 cites W2064018079 @default.
- W2945282678 cites W2064492226 @default.
- W2945282678 cites W2074199206 @default.
- W2945282678 cites W2074366941 @default.
- W2945282678 cites W2074511950 @default.
- W2945282678 cites W2076946807 @default.
- W2945282678 cites W2077850175 @default.
- W2945282678 cites W2084142744 @default.
- W2945282678 cites W2097196651 @default.
- W2945282678 cites W2097383437 @default.
- W2945282678 cites W2100485391 @default.
- W2945282678 cites W2103058881 @default.
- W2945282678 cites W2106440171 @default.
- W2945282678 cites W2109728760 @default.
- W2945282678 cites W2114588704 @default.
- W2945282678 cites W2117402345 @default.
- W2945282678 cites W2122362808 @default.
- W2945282678 cites W2126919962 @default.
- W2945282678 cites W2132613598 @default.
- W2945282678 cites W2139823563 @default.
- W2945282678 cites W2159850054 @default.
- W2945282678 cites W2161923520 @default.
- W2945282678 cites W2166577999 @default.
- W2945282678 cites W2176774871 @default.
- W2945282678 cites W2221305790 @default.
- W2945282678 cites W2255595232 @default.
- W2945282678 cites W2339553358 @default.
- W2945282678 cites W2416604133 @default.
- W2945282678 cites W2494304459 @default.
- W2945282678 cites W2528731190 @default.
- W2945282678 cites W2774743973 @default.
- W2945282678 cites W2901473939 @default.
- W2945282678 cites W2914266286 @default.
- W2945282678 cites W4239684907 @default.
- W2945282678 cites W4240986128 @default.
- W2945282678 doi "https://doi.org/10.3389/fphar.2019.00586" @default.
- W2945282678 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6556973" @default.
- W2945282678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31214029" @default.
- W2945282678 hasPublicationYear "2019" @default.
- W2945282678 type Work @default.
- W2945282678 sameAs 2945282678 @default.
- W2945282678 citedByCount "4" @default.
- W2945282678 countsByYear W29452826782020 @default.
- W2945282678 countsByYear W29452826782022 @default.
- W2945282678 crossrefType "journal-article" @default.
- W2945282678 hasAuthorship W2945282678A5010319430 @default.
- W2945282678 hasAuthorship W2945282678A5031299267 @default.
- W2945282678 hasAuthorship W2945282678A5037090796 @default.
- W2945282678 hasAuthorship W2945282678A5038965879 @default.
- W2945282678 hasAuthorship W2945282678A5044841786 @default.
- W2945282678 hasAuthorship W2945282678A5050497348 @default.
- W2945282678 hasAuthorship W2945282678A5052942089 @default.
- W2945282678 hasAuthorship W2945282678A5074161249 @default.
- W2945282678 hasAuthorship W2945282678A5081254368 @default.
- W2945282678 hasBestOaLocation W29452826781 @default.
- W2945282678 hasConcept C126322002 @default.
- W2945282678 hasConcept C134018914 @default.
- W2945282678 hasConcept C142724271 @default.
- W2945282678 hasConcept C17744445 @default.